%0 Journal Article
%A Sabir, Hemmen
%A Maes, Elke
%A Zweyer, Margit
%A Schleehuber, Yvonne
%A Imam, Farhad B
%A Silverman, Jared
%A White, Yasmine
%A Pang, Raymand
%A Pasca, Anca M
%A Robertson, Nicola J
%A Maltepe, Emin
%A Bernis, Maria Eugenia
%T Comparing the efficacy in reducing brain injury of different neuroprotective agents following neonatal hypoxia-ischemia in newborn rats: a multi-drug randomized controlled screening trial.
%J Scientific reports
%V 13
%N 1
%@ 2045-2322
%C [London]
%I Macmillan Publishers Limited, part of Springer Nature
%M DZNE-2023-00586
%P 9467
%D 2023
%X Intrapartum hypoxia-ischemia leading to neonatal encephalopathy (NE) results in significant neonatal mortality and morbidity worldwide, with > 85
%K Humans
%K Infant, Newborn
%K Animals
%K Rats
%K Neuroprotective Agents: pharmacology
%K Neuroprotective Agents: therapeutic use
%K Animals, Newborn
%K Allopurinol: pharmacology
%K Melatonin: pharmacology
%K Melatonin: therapeutic use
%K Caffeine: pharmacology
%K Clemastine: pharmacology
%K Hedgehog Proteins
%K Brain Injuries: drug therapy
%K Brain
%K Hypothermia, Induced: methods
%K Hypoxia-Ischemia, Brain: drug therapy
%K Hypoxia: drug therapy
%K Hydroxybutyrates: pharmacology
%K Asphyxia Neonatorum: drug therapy
%K Disease Models, Animal
%K Ischemia: therapy
%K Neuroprotective Agents (NLM Chemicals)
%K Allopurinol (NLM Chemicals)
%K Melatonin (NLM Chemicals)
%K Caffeine (NLM Chemicals)
%K Clemastine (NLM Chemicals)
%K Hedgehog Proteins (NLM Chemicals)
%K Hydroxybutyrates (NLM Chemicals)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:37301929
%2 pmc:PMC10257179
%R 10.1038/s41598-023-36653-9
%U https://pub.dzne.de/record/258240